Difference between revisions of "About-cancer/treatment/drugs/recombinant-hpv-quadrivalent-vaccine"
(Marked this version for translation) |
|||
Line 1: | Line 1: | ||
<languages/> | <languages/> | ||
<translate> | <translate> | ||
− | == Recombinant Human Papillomavirus (HPV) Quadrivalent Vaccine == | + | == Recombinant Human Papillomavirus (HPV) Quadrivalent Vaccine == <!--T:1--> |
+ | <!--T:2--> | ||
This page contains brief information about recombinant human papillomavirus (HPV) quadrivalent vaccine and a collection of links to more information about the use of this vaccine, research results, and ongoing clinical trials. | This page contains brief information about recombinant human papillomavirus (HPV) quadrivalent vaccine and a collection of links to more information about the use of this vaccine, research results, and ongoing clinical trials. | ||
+ | <!--T:3--> | ||
'''US Brand Name(s)''' | '''US Brand Name(s)''' | ||
+ | <!--T:4--> | ||
Gardasil | Gardasil | ||
+ | <!--T:5--> | ||
'''FDA Approved''' | '''FDA Approved''' | ||
+ | <!--T:6--> | ||
Yes | Yes | ||
+ | <!--T:7--> | ||
FDA label information for this drug is available at DailyMed. | FDA label information for this drug is available at DailyMed. | ||
+ | <!--T:8--> | ||
'''Use in Cancer''' | '''Use in Cancer''' | ||
+ | <!--T:9--> | ||
Recombinant human papillomavirus (HPV) quadrivalent vaccine is approved to prevent some conditions caused by certain types of HPV. The vaccine protects against four different types of HPV. | Recombinant human papillomavirus (HPV) quadrivalent vaccine is approved to prevent some conditions caused by certain types of HPV. The vaccine protects against four different types of HPV. | ||
+ | <!--T:10--> | ||
It is used in individuals aged 9 to 26 years to prevent the following: | It is used in individuals aged 9 to 26 years to prevent the following: | ||
+ | <!--T:11--> | ||
*'''Anal cancer.''' | *'''Anal cancer.''' | ||
+ | <!--T:12--> | ||
*'''Cervical cancer.''' | *'''Cervical cancer.''' | ||
+ | <!--T:13--> | ||
*'''Vaginal cancer.''' | *'''Vaginal cancer.''' | ||
+ | <!--T:14--> | ||
*'''Vulvar cancer.''' | *'''Vulvar cancer.''' | ||
+ | <!--T:15--> | ||
*'''Lesions''' that sometimes lead to anal, cervical, vaginal, or vulvar cancer. | *'''Lesions''' that sometimes lead to anal, cervical, vaginal, or vulvar cancer. | ||
+ | <!--T:16--> | ||
*'''Genital warts.''' | *'''Genital warts.''' | ||
+ | <!--T:17--> | ||
Recombinant HPV quadrivalent vaccine is no longer available in the United States. It is still used in other countries. | Recombinant HPV quadrivalent vaccine is no longer available in the United States. It is still used in other countries. | ||
+ | <!--T:18--> | ||
'''More About Recombinant Human Papillomavirus (HPV) Quadrivalent Vaccine''' | '''More About Recombinant Human Papillomavirus (HPV) Quadrivalent Vaccine''' | ||
+ | <!--T:19--> | ||
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. | Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. | ||
+ | <!--T:20--> | ||
MedlinePlus Information on Human Papillomavirus (HPV) Vaccine - A lay language summary of important information about this drug that may include the following: | MedlinePlus Information on Human Papillomavirus (HPV) Vaccine - A lay language summary of important information about this drug that may include the following: | ||
+ | <!--T:21--> | ||
*warnings about this drug, | *warnings about this drug, | ||
+ | <!--T:22--> | ||
*what this drug is used for and how it is used, | *what this drug is used for and how it is used, | ||
+ | <!--T:23--> | ||
*what you should tell your doctor before using this drug, | *what you should tell your doctor before using this drug, | ||
+ | <!--T:24--> | ||
*what you should know about this drug before using it, | *what you should know about this drug before using it, | ||
+ | <!--T:25--> | ||
*other drugs that may interact with this drug, and | *other drugs that may interact with this drug, and | ||
+ | <!--T:26--> | ||
*possible side effects. | *possible side effects. | ||
+ | <!--T:27--> | ||
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied. | Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied. | ||
+ | <!--T:28--> | ||
'''Research Results and Related Resources''' | '''Research Results and Related Resources''' | ||
+ | <!--T:29--> | ||
HPV Vaccine May Provide Men with “Herd Immunity” against Oral HPV Infections | HPV Vaccine May Provide Men with “Herd Immunity” against Oral HPV Infections | ||
+ | <!--T:30--> | ||
The HPV Vaccine: Increasing the Use of an Important Cancer Prevention Tool | The HPV Vaccine: Increasing the Use of an Important Cancer Prevention Tool | ||
+ | <!--T:31--> | ||
Cancer Prevention Message Is Key for HPV Vaccination Discussions with Parents | Cancer Prevention Message Is Key for HPV Vaccination Discussions with Parents | ||
+ | <!--T:32--> | ||
HPV Vaccination Linked to Decreased Oral HPV Infections | HPV Vaccination Linked to Decreased Oral HPV Infections | ||
+ | <!--T:33--> | ||
HPV Infections Targeted by Vaccine Decrease in U.S. | HPV Infections Targeted by Vaccine Decrease in U.S. | ||
+ | <!--T:34--> | ||
HPV and Cancer | HPV and Cancer | ||
+ | <!--T:35--> | ||
Vaccine Reduces HPV Infections in Young Men | Vaccine Reduces HPV Infections in Young Men | ||
+ | <!--T:36--> | ||
Human Papillomavirus (HPV) Vaccines | Human Papillomavirus (HPV) Vaccines | ||
+ | <!--T:37--> | ||
'''Clinical Trials Accepting Patients''' | '''Clinical Trials Accepting Patients''' | ||
+ | <!--T:38--> | ||
Find Clinical Trials for Recombinant Human Papillomavirus Quadrivalent Vaccine - Check for trials from NCI's list of cancer clinical trials now accepting patients. | Find Clinical Trials for Recombinant Human Papillomavirus Quadrivalent Vaccine - Check for trials from NCI's list of cancer clinical trials now accepting patients. | ||
+ | <!--T:39--> | ||
Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug. | Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug. | ||
</translate> | </translate> |
Latest revision as of 21:39, 29 October 2019
Recombinant Human Papillomavirus (HPV) Quadrivalent Vaccine
This page contains brief information about recombinant human papillomavirus (HPV) quadrivalent vaccine and a collection of links to more information about the use of this vaccine, research results, and ongoing clinical trials.
US Brand Name(s)
Gardasil
FDA Approved
Yes
FDA label information for this drug is available at DailyMed.
Use in Cancer
Recombinant human papillomavirus (HPV) quadrivalent vaccine is approved to prevent some conditions caused by certain types of HPV. The vaccine protects against four different types of HPV.
It is used in individuals aged 9 to 26 years to prevent the following:
- Anal cancer.
- Cervical cancer.
- Vaginal cancer.
- Vulvar cancer.
- Lesions that sometimes lead to anal, cervical, vaginal, or vulvar cancer.
- Genital warts.
Recombinant HPV quadrivalent vaccine is no longer available in the United States. It is still used in other countries.
More About Recombinant Human Papillomavirus (HPV) Quadrivalent Vaccine
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Human Papillomavirus (HPV) Vaccine - A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Research Results and Related Resources
HPV Vaccine May Provide Men with “Herd Immunity” against Oral HPV Infections
The HPV Vaccine: Increasing the Use of an Important Cancer Prevention Tool
Cancer Prevention Message Is Key for HPV Vaccination Discussions with Parents
HPV Vaccination Linked to Decreased Oral HPV Infections
HPV Infections Targeted by Vaccine Decrease in U.S.
HPV and Cancer
Vaccine Reduces HPV Infections in Young Men
Human Papillomavirus (HPV) Vaccines
Clinical Trials Accepting Patients
Find Clinical Trials for Recombinant Human Papillomavirus Quadrivalent Vaccine - Check for trials from NCI's list of cancer clinical trials now accepting patients.
Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.